U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

First-Time Generics - May 2003

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 MOEXIPRIL HYDROCHLORIDE TABLETS 7.5 MG AND 15 MG TEVA PHARMACEUTICALS USA UNIVASC TABLETS 5/8/2003 
2 BETAMETHASONE DIPROPIONATE GEL 0.05% (BASE) ALTANA INC. DIPROLENE GEL 5/13/2003 
3 BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2% BAUSCH & LOMB PHARMACEUTICALS, INC. ALPHAGAN OPHTHALMIC SOLUTION 5/28/2003 
4 QUINAPRIL HYDROCHLORIDE TABLETS 5 MG, 10 MG, 20 MG, AND 40 MG TEVA PHARMACEUTICALS USA ACCUPRIL TABLETS 5/30/2003 
5 NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS, USP 1 MG/0.02 MG (21-DAY CYCLE) BARR LABORATORIES, INC. LOESTRIN-21 1/20 5/30/2003 
6 NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS, USP 1.5 MG/0.03 MG (21-DAY CYCLE) BARR LABORATORIES, INC. LOESTRIN-21 1.5/30 5/30/2003 

 Back Back to Approvals

FDA/Center for Drug Evaluation and Research
Last Updated: June 4, 2003
Originator: OTCOM/OGD
HTML by SJW